Racial Differences and Contributory Cardiovascular and Non-Cardiovascular Risk Factors Towards Chronic Kidney Disease Progression

References

• Centers for Disease Control and Prevention. Chronic kidney disease surveillance system—United States. Available from: http://www.cdc.gov/ckd. Accessed December 12, 2022.
   Google Scholar
• Shen Y, Cai R, Sun J, et al. Diabetes mellitus as a risk factor for incident chronic kidney disease and end-stage renal disease in women compared with men: a systematic review and meta-analysis. Endocrine. 2017;55(1):66–76. doi:10.1007/s12020-016-1014-6
   PubMed Web of Science ®Google Scholar
• Weldegiorgis M, Woodward M. The impact of hypertension on chronic kidney disease and end-stage renal disease is greater in men than women: a systematic review and meta-analysis. BMC Nephrol. 2020;21(1):506. doi:10.1186/s12882-020-02151-7
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Chronic Kidney Disease in the United States, 2019. Atlanta, GA: Department of Health and Human Services, Centers for Disease Control and Prevention; 2019.
   Google Scholar
• Hall ME, Do Carmo JM, da Silva AA, Juncos LA, Wang Z, Hall JE. Obesity, hypertension, and chronic kidney disease. Int J Nephrol Renovasc Dis. 2014;7:75–88. doi:10.2147/IJNRD.S39739
   PubMedGoogle Scholar
• Centers for Disease Control and Prevention. Hypertension Cascade: Hypertension Prevalence, Treatment and Control Estimates Among U.S. Adults Aged 18 Years and Older Applying the Criteria from the American College of Cardiology and American Heart Association’s 2017 Hypertension Guideline—NHANES 2015–2018. Atlanta, GA: Department of Health and Human Services; 2021.
   Google Scholar
• Centers for Disease Control and Prevention. National Diabetes Statistics Report, 2020. Atlanta, GA: Centers for Disease Control and Prevention, U.S. Dept of Health and Human Services; 2020.
   Google Scholar
• Norton JM, Moxey-Mims MM, Eggers PW, et al. Social determinants of racial disparities in CKD. J Am Soc Nephrol. 2016;27(9):2576–2595. doi:10.1681/ASN.2016010027
   PubMed Web of Science ®Google Scholar
• Peralta CA, Katz R, DeBoer I, et al. Racial and ethnic differences in kidney function decline among persons without chronic kidney disease. J Am Soc Nephrol. 2011;22(7):1327–1334. doi:10.1681/ASN.2010090960
   PubMed Web of Science ®Google Scholar
• Choi Y, Jacobs DR, Shroff GR, Kramer H, Chang AR, Duprez DA. Progression of chronic kidney disease risk categories and risk of cardiovascular disease and total mortality: coronary artery risk development in young adults cohort. J Am Heart Assoc. 2022;11(21):e026685. doi:10.1161/JAHA.122.026685
   PubMed Web of Science ®Google Scholar
• Choi Y, Jacobs DR, Kramer HJ, Shroff GR, Chang AR, Duprez DA. Non-traditional risk factors for progression through chronic kidney disease risk categories: the coronary artery risk development in young adults study. Am J Med. 2022;S0002–9343(22):887. doi:10.1016/j.amjmed.2022.12.001
   Google Scholar
• Husain-Syed F, Slutsky AS, Ronco C. Lung-kidney cross-talk in the critically ill patient. Am J Respir Crit Care Med. 2016;194(4):402–414. doi:10.1164/rccm.201602-0420CP
   PubMed Web of Science ®Google Scholar
• Sorino C, Scichilone N, Pedone C, Negri S, Visca D, Spanevello A. When kidneys and lungs suffer together. J Nephrol. 2019;32(5):699–707. doi:10.1007/s40620-018-00563-1
   PubMed Web of Science ®Google Scholar
• Chandra D, Stamm JA, Palevsky PM, et al. The relationship between pulmonary emphysema and kidney function in smokers. Chest. 2012;142(3):655–662. doi:10.1378/chest.11-1456
   PubMed Web of Science ®Google Scholar
• Harris B, Klein R, Jerosch-Herold M, et al. The association of systemic microvascular changes with lung function and lung density: a cross-sectional study. PLoS One. 2012;7(12):e50224. doi:10.1371/journal.pone.0050224
   PubMed Web of Science ®Google Scholar
• Jourde-Chiche N, Fakhouri F, Dou L, et al. Endothelium structure and function in kidney health and disease. Nat Rev Nephrol. 2019;15(2):87–108. doi:10.1038/s41581-018-0098-z
   PubMed Web of Science ®Google Scholar
• Kumagai T, Ota T, Tamura Y, Chang WX, Shibata S, Uchida S. Time to target uric acid to retard CKD progression. Clin Exp Nephrol. 2017;21(2):182–192. doi:10.1007/s10157-016-1288-2
   PubMed Web of Science ®Google Scholar
• Pan J, Shi M, Ma L, Fu P. Mechanistic insights of soluble uric acid-related kidney disease. Curr Med Chem. 2020;27(30):5056–5066. doi:10.2174/0929867326666181211094421
   PubMed Web of Science ®Google Scholar
• Ejaz AA, Nakagawa T, Kanbay M, et al. Hyperuricemia in kidney disease: a major risk factor for cardiovascular events, vascular calcification, and renal damage. Semin Nephrol. 2020;40(6):574–585. doi:10.1016/j.semnephrol.2020.12.004
   PubMed Web of Science ®Google Scholar
• Hozawa A, Jacobs DR, Steffes MW, Gross MD, Steffen LM, Lee DH. Relationships of circulating carotenoid concentrations with several markers of inflammation, oxidative stress, and endothelial dysfunction: the coronary artery risk development in young adults (CARDIA)/young adult longitudinal trends in antioxidants (YALTA) study. Clin Chem. 2007;53(3):447–455. doi:10.1373/clinchem.2006.074930
   PubMed Web of Science ®Google Scholar
• Di Pietro N, Baldassarre MPA, Cichelli A, Pandolfi A, Formoso G, Pipino C. Role of polyphenols and carotenoids in endothelial dysfunction: an overview from classic to innovative biomarkers. Oxid Med Cell Longev. 2020;2020:6381380. doi:10.1155/2020/6381380
   PubMed Web of Science ®Google Scholar
• Friedman GD, Cutter GR, Donahue RP, et al. CARDIA: study design, recruitment, and some characteristics of the examined subjects. J Clin Epidemiol. 1988;41(11):1105–1116. doi:10.1016/0895-4356(88)90080-7
   PubMed Web of Science ®Google Scholar
• Murtaugh MA, Jacobs DR, Yu X, Gross MD, Steffes M. Coronary artery risk development in young adults study. Correlates of urinary albumin excretion in young adult blacks and whites: the coronary artery risk development in young adults study. Am J Epidemiol. 2003;158(7):676–686. doi:10.1093/aje/kwg208
   PubMed Web of Science ®Google Scholar
• Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–612. doi:10.7326/0003-4819-150-9-200905050-00006
   PubMed Web of Science ®Google Scholar
• Delgado C, Baweja M, Crews DC, et al. A unifying approach for GFR estimation: recommendations of the NKF-ASN task force on reassessing the inclusion of race in diagnosing kidney disease. Am J Kidney Dis. 2022;79(2):268–288.e1. doi:10.1053/j.ajkd.2021.08.003
   PubMed Web of Science ®Google Scholar
• Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013;3:1–150.
   Web of Science ®Google Scholar
• Thyagarajan B, Jacobs DR, Apostol GG, et al. Longitudinal association of body mass index with lung function: the CARDIA study. Respir Res. 2008;9:31. doi:10.1186/1465-9921-9-31
   PubMed Web of Science ®Google Scholar
• Bancks MP, Carnethon MR, Chow LS, et al. Fasting glucose and insulin resistance trajectories during young adulthood and mid-life cardiac structure and function. J Diabetes Complications. 2019;33(5):356–362. doi:10.1016/j.jdiacomp.2019.01.005
   PubMed Web of Science ®Google Scholar
• Warnick GR, Benderson J, Albers JJ. Dextran sulfate-Mg2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol. Clin Chem. 1982;28(6):1379–1388. doi:10.1093/clinchem/28.6.1379
   PubMed Web of Science ®Google Scholar
• Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18(6):499–502. doi:10.1093/clinchem/18.6.499
   PubMed Web of Science ®Google Scholar
• Fossati P, Prencipe L, Berti G. Use of 3,5-dichloro-2-hydroxybenzenesulfonic acid/4-aminophenazone chromogenic system in direct enzymic assay of uric acid in serum and urine. Clin Chem. 1980;26(2):227–231. doi:10.1093/clinchem/26.2.227
   PubMed Web of Science ®Google Scholar
• Rifai N, Tracy RP, Ridker PM. Clinical efficacy of an automated high-sensitivity C-reactive protein assay. Clin Chem. 1999;45(12):2136–2141. doi:10.1093/clinchem/45.12.2136
   PubMed Web of Science ®Google Scholar
• Otvos JD, Shalaurova I, Wolak-Dinsmore J, et al. GlycA: a composite nuclear magnetic resonance biomarker of systemic inflammation. Clin Chem. 2015;61(5):714–723. doi:10.1373/clinchem.2014.232918
   PubMed Web of Science ®Google Scholar
• Jeyarajah EJ, Cromwell WC, Otvos JD. Lipoprotein particle analysis by nuclear magnetic resonance spectroscopy. Clin Lab Med. 2006;26(4):847–870. doi:10.1016/j.cll.2006.07.006
   PubMed Web of Science ®Google Scholar
• Lee DH, Gross MD, Jacobs DR. cardiovascular risk development in young adults study. Association of serum carotenoids and tocopherols with gamma-glutamyltransferase: the cardiovascular risk development in young adults (CARDIA) study. Clin Chem. 2004;50(3):582–588. doi:10.1373/clinchem.2003.028852
   PubMed Web of Science ®Google Scholar
• Bieri JG, Brown ED, Smith JC. Determination of individual carotenoids in human plasma by high performance liquid chromatography. J Liq Chromatogr. 1985;8:473–484. doi:10.1080/01483918508067094
   Web of Science ®Google Scholar
• American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2014;37(1):S81–90. doi:10.2337/dc14-S081
   PubMed Web of Science ®Google Scholar
• Grams ME, Chow EKH, Segev DL, Coresh J. Lifetime incidence of CKD stages 3–5 in the United States. Am J Kidney Dis. 2013;62(2):245–252. doi:10.1053/j.ajkd.2013.03.009
   PubMed Web of Science ®Google Scholar
• Muntner P, Newsome B, Kramer H, et al. Racial differences in the incidence of chronic kidney disease. Clin J Am Soc Nephrol. 2012;7(1):101–107. doi:10.2215/CJN.06450611
   PubMed Web of Science ®Google Scholar
• Harik-Khan RI, Muller DC, Wise RA. Racial difference in lung function in African-American and White children: effect of anthropometric, socioeconomic, nutritional, and environmental factors. Am J Epidemiol. 2004;160(9):893–900. doi:10.1093/aje/kwh297
   PubMed Web of Science ®Google Scholar
• Jacobs DR, Nelson ET, Dontas AS, Keller J, Slattery ML, Higgins M. Are race and sex differences in lung function explained by frame size? The CARDIA Study. Am Rev Respir Dis. 1992;146(3):644–649. doi:10.1164/ajrccm/146.3.644
   PubMedGoogle Scholar
• Quiñones AR, Botoseneanu A, Markwardt S, et al. Racial/ethnic differences in multimorbidity development and chronic disease accumulation for middle-aged adults. PLoS One. 2019;14(6):e0218462. doi:10.1371/journal.pone.0218462
   PubMed Web of Science ®Google Scholar
• Johansen KL, Chertow GM, Gilbertson DT, et al. US renal data system 2021 annual data report: epidemiology of kidney disease in the United States. Am J Kidney Dis. 2022;79(4 Suppl 1):A8–A12. doi:10.1053/j.ajkd.2022.02.001
   PubMed Web of Science ®Google Scholar
• Choi Y, Jacobs DR, Bancks MP, et al. Association of cardiovascular health score with early- and later-onset diabetes and with subsequent vascular complications of diabetes. J Am Heart Assoc. 2022;12:e027558. doi:10.1161/JAHA.122.027558
   PubMed Web of Science ®Google Scholar
• Bae EH, Lim SY, Kim B, et al. Effects of blood pressure according to age on end-stage renal disease development in patients with diabetes: a nationwide population-based cohort study. Hypertension. 2022;79(8):1765–1776. doi:10.1161/HYPERTENSIONAHA.121.18881
   PubMed Web of Science ®Google Scholar
• Crews DC, Pfaff T, Powe NR. Socioeconomic factors and racial disparities in kidney disease outcomes. Semin Nephrol. 2013;33(5):468–475. doi:10.1016/j.semnephrol.2013.07.008
   PubMed Web of Science ®Google Scholar
• Whitaker KM, Jacobs DR, Kershaw KN, et al. Racial disparities in cardiovascular health behaviors: the coronary artery risk development in young adults study. Am J Prev Med. 2018;55(1):63–71. doi:10.1016/j.amepre.2018.03.017
   PubMed Web of Science ®Google Scholar
• Song C, Bancks MP, Whitaker KM, et al. Contribution of social, behavioral, and contextual exposures to black-white disparities in incident obesity: the CARDIA study. Obesity. 2023;2023:1.
   Google Scholar
• Shah NS, Ning H, Petito LC, et al. Associations of clinical and social risk factors with racial differences in premature cardiovascular disease. Circulation. 2022;146(3):201–210. doi:10.1161/CIRCULATIONAHA.121.058311
   PubMed Web of Science ®Google Scholar
• Peralta CA, Bibbins-Domingo K, Vittinghoff E, et al. APOL1 genotype and race differences in incident albuminuria and renal function decline. J Am Soc Nephrol. 2016;27(3):887–893. doi:10.1681/ASN.2015020124
   PubMed Web of Science ®Google Scholar